$INFI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INFINITY PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INFINITY PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INFINITY PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2021 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.14 | 568,019 | 2,350,917 | 686,974 | 1.3 M to 687 K (-45.26 %) |
Jan 26 2021 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.14 | 2,458,838 | 10,176,639 | 4,172,298 | 6.6 M to 4.2 M (-37.08 %) |
Jan 26 2021 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.14 | 2,821,663 | 11,678,299 | 5,663,912 | 8.5 M to 5.7 M (-33.25 %) |
Dec 23 2020 | INFI | INFINITY PHARMACEU ... | Tasker Seth A | Chief Business Offi ... | Option Exercise | A | 2.14 | 250,000 | 535,000 | 250,000 | |
Dec 23 2020 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Option Exercise | A | 2.14 | 335,000 | 716,900 | 335,000 | |
Dec 23 2020 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 2.14 | 485,000 | 1,037,900 | 485,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 0.92 | 30,000 | 27,600 | 30,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 0.92 | 10,000 | 9,200 | 10,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 0.92 | 30,000 | 27,600 | 30,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | BEIER DAVID W | Director | Option Exercise | A | 0.92 | 30,000 | 27,600 | 30,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | Agresta Samuel | Director | Option Exercise | A | 0.92 | 30,000 | 27,600 | 30,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 0.92 | 30,000 | 27,600 | 30,000 | |
Jun 18 2020 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 0.00 | 22,826 | 0 | 165,964 | 143.1 K to 166 K (+15.95 %) |
Mar 17 2020 | INFI | INFINITY PHARMACEU ... | GAYNOR RICHARD | Director | Option Exercise | A | 0.69 | 60,000 | 41,100 | 60,000 | |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Tasker Seth A | Chief Business Offi ... | Option Exercise | A | 1.25 | 412,500 | 515,625 | 412,500 | |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Tasker Seth A | Chief Business Offi ... | Grant | A | 0.00 | 53,538 | 0 | 101,364 | 47.8 K to 101.4 K (+111.94 %) |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Option Exercise | A | 1.25 | 418,750 | 523,438 | 418,750 | |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Grant | A | 0.00 | 83,157 | 0 | 745,094 | 661.9 K to 745.1 K (+12.56 %) |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 1.25 | 450,000 | 562,500 | 450,000 | |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Grant | A | 0.00 | 64,219 | 0 | 77,376 | 13.2 K to 77.4 K (+488.10 %) |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 1.25 | 606,250 | 757,813 | 606,250 | |
Jan 13 2020 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Grant | A | 0.00 | 155,134 | 0 | 793,190 | 638.1 K to 793.2 K (+24.31 %) |
Oct 16 2019 | INFI | INFINITY PHARMACEU ... | Agresta Samuel | Director | Option Exercise | A | 1.14 | 60,000 | 68,400 | 60,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 30,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 1.60 | 13,125 | 21,000 | 143,138 | 130 K to 143.1 K (+10.10 %) |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.60 | 10,000 | 16,000 | 0 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 0 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | BEIER DAVID W | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 30,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 30,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Option Exercise | A | 1.24 | 100,000 | 124,000 | 100,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | Kauffman Michael | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 30,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 1.24 | 242,000 | 300,080 | 242,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Option Exercise | A | 1.60 | 30,000 | 48,000 | 30,000 | |
Jun 14 2019 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Grant | A | 1.60 | 26,250 | 42,000 | 85,238 | 59 K to 85.2 K (+44.50 %) |
Jan 07 2019 | INFI | INFINITY PHARMACEU ... | Tasker Seth A | General Counsel | Option Exercise | A | 1.24 | 140,000 | 173,600 | 140,000 | |
Jan 07 2019 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Option Exercise | A | 1.24 | 335,000 | 415,400 | 335,000 | |
Jan 07 2019 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 1.24 | 155,000 | 192,200 | 155,000 | |
Jan 07 2019 | INFI | INFINITY PHARMACEU ... | Agresta Samuel | Chief Medical Offic ... | Option Exercise | A | 1.24 | 62,596 | 77,619 | 62,596 | |
Jan 07 2019 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 1.24 | 243,000 | 301,320 | 243,000 | |
Dec 17 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.20 | 120,539 | 144,587 | 6,631,136 | 6.5 M to 6.6 M (+1.85 %) |
Dec 17 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.20 | 54,461 | 65,326 | 8,485,575 | 8.4 M to 8.5 M (+0.65 %) |
Nov 30 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.30 | 100,000 | 130,000 | 6,510,597 | 6.4 M to 6.5 M (+1.56 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 581 | 784 | 1,254,993 | 1.3 M to 1.3 M (+0.05 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 4,119 | 5,561 | 8,431,114 | 8.4 M to 8.4 M (+0.05 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 5,573 | 7,524 | 1,254,412 | 1.2 M to 1.3 M (+0.45 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 38,001 | 51,301 | 6,410,597 | 6.4 M to 6.4 M (+0.60 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 50,044 | 67,559 | 8,426,995 | 8.4 M to 8.4 M (+0.60 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.37 | 81,648 | 111,841 | 1,248,839 | 1.2 M to 1.2 M (+7.00 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.37 | 556,709 | 762,580 | 6,372,596 | 5.8 M to 6.4 M (+9.57 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.37 | 733,151 | 1,004,270 | 8,376,951 | 7.6 M to 8.4 M (+9.59 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 39,074 | 52,750 | 5,815,887 | 5.8 M to 5.8 M (+0.68 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 52,400 | 70,740 | 7,643,800 | 7.6 M to 7.6 M (+0.69 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 92,960 | 124,566 | 5,776,813 | 5.7 M to 5.8 M (+1.64 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 117,290 | 157,169 | 7,591,400 | 7.5 M to 7.6 M (+1.57 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 562,754 | 759,718 | 5,683,853 | 5.1 M to 5.7 M (+10.99 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 41,454 | 55,963 | 7,474,110 | 7.4 M to 7.5 M (+0.56 %) |
Oct 02 2018 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Sell | S | 2.82 | 5,000 | 14,100 | 609,561 | 614.6 K to 609.6 K (-0.81 %) |
Aug 17 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Sell | S | 2.00 | 6,133 | 12,266 | 0 | 6.1 K to 0 (-100.00 %) |
Aug 17 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Sell | S | 2.01 | 8,180 | 16,421 | 6,133 | 14.3 K to 6.1 K (-57.15 %) |
Aug 07 2018 | INFI | INFINITY PHARMACEU ... | Agresta Samuel | Chief Medical Offic ... | Option Exercise | A | 1.80 | 300,000 | 540,000 | 300,000 | |
Jun 25 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Sell | S | 2.00 | 14,313 | 28,695 | 14,313 | 28.6 K to 14.3 K (-50.00 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 36,825 | 60,761 | 1,167,191 | 1.1 M to 1.2 M (+3.26 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 158,151 | 260,949 | 5,121,099 | 5 M to 5.1 M (+3.19 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 230,555 | 380,416 | 7,432,656 | 7.2 M to 7.4 M (+3.20 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 179,893 | 296,823 | 1,130,366 | 950.5 K to 1.1 M (+18.93 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 1,419,907 | 2,342,847 | 4,962,948 | 3.5 M to 5 M (+40.08 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 1,916,760 | 3,162,654 | 7,202,101 | 5.3 M to 7.2 M (+36.27 %) |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.75 | 2,000 | 3,500 | 2,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.75 | 10,000 | 17,500 | 10,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Grant | A | 1.75 | 22,857 | 40,000 | 58,988 | 36.1 K to 59 K (+63.26 %) |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.75 | 4,000 | 7,000 | 4,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Grant | A | 1.75 | 22,857 | 40,000 | 45,845 | 23 K to 45.8 K (+99.43 %) |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.75 | 2,000 | 3,500 | 2,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 1.75 | 11,428 | 19,999 | 130,013 | 118.6 K to 130 K (+9.64 %) |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | Kauffman Michael | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 1.75 | 4,000 | 7,000 | 4,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
Jun 14 2018 | INFI | INFINITY PHARMACEU ... | BEIER DAVID W | Director | Grant | A | 1.75 | 5,714 | 10,000 | 5,714 | 0 to 5.7 K |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.00 | 97,453 | 194,906 | 950,473 | 853 K to 950.5 K (+11.42 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.00 | 365,682 | 731,364 | 3,543,041 | 3.2 M to 3.5 M (+11.51 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.00 | 546,865 | 1,093,730 | 5,285,341 | 4.7 M to 5.3 M (+11.54 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 62,437 | 118,630 | 853,020 | 790.6 K to 853 K (+7.90 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 208,872 | 396,857 | 3,177,359 | 3 M to 3.2 M (+7.04 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 228,691 | 434,513 | 4,738,476 | 4.5 M to 4.7 M (+5.07 %) |
Apr 02 2018 | INFI | INFINITY PHARMACEU ... | BEIER DAVID W | Director | Option Exercise | A | 2.10 | 40,000 | 84,000 | 40,000 | |
Mar 07 2018 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Sell | S | 2.78 | 5,000 | 13,890 | 607,252 | 612.3 K to 607.3 K (-0.82 %) |
Jan 09 2018 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 1.99 | 500,000 | 992,500 | 500,000 | |
Jan 04 2018 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 2.23 | 180,000 | 401,400 | 180,000 | |
Jan 04 2018 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Grant | A | 0.00 | 69,924 | 0 | 612,252 | 542.3 K to 612.3 K (+12.89 %) |
Jan 04 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 2.23 | 70,000 | 156,100 | 70,000 | |
Jan 04 2018 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Grant | A | 0.00 | 28,626 | 0 | 28,626 | 0 to 28.6 K |
Jan 04 2018 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Option Exercise | A | 2.23 | 100,000 | 223,000 | 100,000 | |
Jan 04 2018 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Grant | A | 0.00 | 37,881 | 0 | 626,133 | 588.3 K to 626.1 K (+6.44 %) |
Dec 07 2017 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Buy | P | 1.81 | 500,000 | 905,000 | 580,944 | 80.9 K to 580.9 K (+617.71 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 63,042 | 80,946 | 790,583 | 727.5 K to 790.6 K (+8.67 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 235,326 | 302,159 | 2,968,487 | 2.7 M to 3 M (+8.61 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 355,081 | 455,924 | 4,509,785 | 4.2 M to 4.5 M (+8.55 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.24 | 28,918 | 35,714 | 727,541 | 698.6 K to 727.5 K (+4.14 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.24 | 394,078 | 486,686 | 2,733,161 | 2.3 M to 2.7 M (+16.85 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.24 | 523,601 | 646,647 | 4,154,704 | 3.6 M to 4.2 M (+14.42 %) |
Jul 24 2017 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Grant | A | 0.00 | 85,800 | 0 | 535,020 | 449.2 K to 535 K (+19.10 %) |
Jul 24 2017 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Grant | A | 0.00 | 39,039 | 0 | 80,944 | 41.9 K to 80.9 K (+93.16 %) |
Jul 24 2017 | INFI | INFINITY PHARMACEU ... | Tasker Seth A | General Counsel | Grant | A | 0.00 | 8,916 | 0 | 17,833 | 8.9 K to 17.8 K (+99.99 %) |
May 26 2017 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.74 | 2,000 | 3,480 | 2,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.74 | 10,000 | 17,400 | 10,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.74 | 20,000 | 34,800 | 20,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Option Exercise | A | 1.74 | 250,000 | 435,000 | 250,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Option Exercise | A | 1.74 | 20,000 | 34,800 | 20,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Grant | A | 1.74 | 5,747 | 10,000 | 36,131 | 30.4 K to 36.1 K (+18.91 %) |
May 26 2017 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.74 | 2,000 | 3,480 | 2,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.74 | 20,000 | 34,800 | 20,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Grant | A | 1.74 | 11,494 | 20,000 | 118,585 | 107.1 K to 118.6 K (+10.73 %) |
May 26 2017 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.74 | 4,000 | 6,960 | 4,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.74 | 20,000 | 34,800 | 20,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Grant | A | 1.74 | 22,988 | 39,999 | 22,988 | 0 to 23 K |
May 26 2017 | INFI | INFINITY PHARMACEU ... | Kutok Jeffery | Chief Scientific Of ... | Option Exercise | A | 1.74 | 125,000 | 217,500 | 125,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 1.74 | 4,000 | 6,960 | 4,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 1.74 | 20,000 | 34,800 | 20,000 | |
May 26 2017 | INFI | INFINITY PHARMACEU ... | Tasker Seth A | General Counsel | Option Exercise | A | 1.74 | 150,000 | 261,000 | 150,000 | |
Apr 06 2017 | INFI | INFINITY PHARMACEU ... | Kauffman Michael | Director | Option Exercise | A | 2.80 | 40,000 | 112,000 | 40,000 | |
Mar 20 2017 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Sell | S | 3.48 | 6,250 | 21,750 | 50,000 | 56.3 K to 50 K (-11.11 %) |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 1.46 | 40,000 | 58,400 | 40,000 | |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 1.46 | 40,000 | 58,400 | 40,000 | |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 1.46 | 40,000 | 58,400 | 40,000 | |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 1.46 | 40,000 | 58,400 | 40,000 | |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Chief Executive Off ... | Option Exercise | A | 1.46 | 1,000,000 | 1,460,000 | 1,000,000 | |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | Baselga Jose | Director | Option Exercise | A | 1.46 | 40,000 | 58,400 | 40,000 | |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | President | Option Exercise | A | 1.46 | 500,000 | 730,000 | 500,000 | |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | Tasker Seth A | General Counsel | Option Exercise | A | 1.46 | 250,000 | 365,000 | 250,000 | |
Jan 09 2017 | INFI | INFINITY PHARMACEU ... | Berkowitz Jeffrey | Director | Option Exercise | A | 1.46 | 40,000 | 58,400 | 40,000 | |
Jan 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 3,234 | 4,333 | 2,339,083 | 2.3 M to 2.3 M (+0.14 %) |
Jan 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 1,145 | 1,534 | 3,631,103 | 3.6 M to 3.6 M (+0.03 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 1,205 | 1,614 | 2,335,849 | 2.3 M to 2.3 M (+0.05 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 2,348 | 3,145 | 3,629,958 | 3.6 M to 3.6 M (+0.06 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 77,076 | 102,943 | 698,623 | 621.5 K to 698.6 K (+12.40 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 260,046 | 347,317 | 2,334,644 | 2.1 M to 2.3 M (+12.53 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 401,726 | 536,545 | 3,627,610 | 3.2 M to 3.6 M (+12.45 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 2,244 | 3,040 | 621,547 | 619.3 K to 621.5 K (+0.36 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 8,111 | 10,990 | 2,074,598 | 2.1 M to 2.1 M (+0.39 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 11,646 | 15,779 | 3,225,884 | 3.2 M to 3.2 M (+0.36 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 21,021 | 28,555 | 619,303 | 598.3 K to 619.3 K (+3.51 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 69,041 | 93,785 | 2,066,487 | 2 M to 2.1 M (+3.46 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 108,202 | 146,982 | 3,214,238 | 3.1 M to 3.2 M (+3.48 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 47,812 | 61,199 | 598,282 | 550.5 K to 598.3 K (+8.69 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 150,451 | 192,577 | 1,997,446 | 1.8 M to 2 M (+8.15 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 236,393 | 302,583 | 3,106,036 | 2.9 M to 3.1 M (+8.24 %) |